The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


INSUMAN BASAL 40IU/ML

40 International Unit Suspension for Injection

Sanofi-Aventis Deutschland GmbHEU/1/97/030/036

Main Information

Trade NameINSUMAN BASAL 40IU/ML
Active SubstancesINSULIN HUMAN
Strength40 International Unit
Dosage FormSuspension for Injection
Licence HolderSanofi-Aventis Deutschland GmbH
Licence NumberEU/1/97/030/036

Group Information

ATC CodeA10AC01 insulin (human)

Status

Authorised/WithdrawnAuthorised
Licence Issued11/11/1998
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusUnknown

Documents

Summary of Product CharacteristicsSearch EMA website
Package LeafletSearch EMA website
Public Assessment ReportSearch EMA website
« Back